Editor’s Note April 3, 2012
Spring represents new beginnings, and while things are just starting to heat up on the outside, the healthcare and life science industry is on fire. […]
Crowdfunding: Politicians Love the JOBS Act, Why Investors May Not
Despite political contention over the influence of corporate America in shaping the American Dream, our nation’s leaders tend to unite in their respect of small business.
Diagnostics in South Asia
India, the world’s largest democracy, has seen dramatic changes in diagnostic developments. The Hindu, a daily newspaper focusing on India and abroad, reported that India has the highest number of multidrug-resistant TB in South East Asia.
This Week In Diagnostics
Peter Winter, consultant to the biotechnology industry brings us financings and business developments in the global diagnostics business in his column “This Week In Diagnostics“. Peter has over 30 years experience as a scientist, science journalist, and publisher.
The Magazine For Decision Makers in a Global Industry Launches in NYC
New Pharma Magazine celebrated the launch of the first edition in New York City last week by partnering with the Drug Chemical and Associated Technologies Association.
Brachytherapy: Why Chemotherapy May Soon Be a Thing of the Past
Brachytherapy is considered to be one of the oldest techniques for the treatment of various cancers, particularly for prostate cancer.
May 2 – 3 2012, NYBA 21st Annual Meeting
New York Biotechnology Association (NYBA) will develop its Emerging Companies Showcase through a partnership with OneMedPlace.
“Brooklyn Doc Billionaire” Will Unveil Potential Cure For AIDS
The film will focus on current biotechnology “innovation-stagnation” , the current cost of drug development and its stages, and conflicts of interest based on human defense concepts.
This Week In Diagnostics
Peter Winter, consultant to the biotechnology industry brings us financings and business developments in the global diagnostics business in his column “This Week In Diagnostics“. Peter has over 30 years experience as a scientist, science journalist, and publisher.
Risk Trends Among Financiers in Healthcare
Richard Day Research, a leading clinical research organization, is conducting an evaluation on risk trends among financiers in the healthcare field. The insights of leading investors are a critical part of assessing shifts in the healthcare landscape.